Biosimilar Newsletter Archive

11. 03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars 3/6/2025
    03/06/25 Biosimilar Development Newsletter
12. 02.27.25 -- A New Approach For Minimizing Human Errors In Biopharmaceuticals 2/27/2025
    02/27/25 Biosimilar Development Newsletter
13. 02.20.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/20/2025
    02/20/25 Biosimilar Development Newsletter
14. 02.13.25 -- Using Simple Spreadsheet DoE To Optimize The Protein Pipeline 2/13/2025
    02/13/25 Biosimilar Development Newsletter
15. 02.06.25 -- Developing ADCs? A Refresher On HPAPI Occupational Health Risk Mitigation 2/6/2025
    02/06/25 Biosimilar Development Newsletter
16. 01.30.25 -- New Regulatory Survey Findings: Biotech Market Access Challenges 1/30/2025
    01/30/25 Biosimilar Development Newsletter
17. 01.23.25 -- How To Establish A Win-Win Relationship With Your CDMO 1/23/2025
    01/23/25 Biosimilar Development Newsletter
18. 01.16.25 -- Become A cGMP "Special Agent" With A License To Care 1/16/2025
    01/16/25 Biosimilar Development Newsletter
19. 01.09.25 -- AP Biosciences' Approach To Complex Antibody Manufacturing 1/9/2025
    01/09/25 Biosimilar Development Newsletter
20. 01.02.25 -- Cell Culture Trends To Watch In 2025 1/2/2025
    01/02/25 Biosimilar Development Newsletter